SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-20-216465
Filing Date
2020-08-11
Accepted
2020-08-11 17:11:17
Documents
6
Effectiveness Date
2020-08-11

Document Format Files

Seq Description Document Type Size
1 S-3ASR d941995ds3asr.htm S-3ASR 227862
2 EX-4.3 d941995dex43.htm EX-4.3 298203
3 EX-5.1 d941995dex51.htm EX-5.1 21858
4 EX-23.2 d941995dex232.htm EX-23.2 1532
5 GRAPHIC g941995dsp001.jpg GRAPHIC 12703
6 GRAPHIC g941995g79j32.jpg GRAPHIC 42714
  Complete submission text file 0001193125-20-216465.txt   620190
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-244401 | Film No.: 201093305
SIC: 2834 Pharmaceutical Preparations